Basit öğe kaydını göster

dc.contributor.authorDegertekin, Ceyla Konca
dc.contributor.authorYavuz, Dilek Gogas
dc.contributor.authorPekkolay, Zafer
dc.contributor.authorSaygili, Emre
dc.contributor.authorUgur, Kader
dc.contributor.authorKoca, Arzu Or
dc.contributor.authorUnubol, Mustafa
dc.date.accessioned2024-03-12T19:28:50Z
dc.date.available2024-03-12T19:28:50Z
dc.date.issued2022
dc.identifier.issn0171-967X
dc.identifier.issn1432-0827
dc.identifier.urihttps://doi.org/10.1007/s00223-021-00908-2
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2070
dc.description.abstractHypoparathyroidism is an orphan disease with ill-defined epidemiology that is subject to geographic variability. We conducted this study to assess the demographics, etiologic distribution, treatment patterns and complication frequency of patients with chronic hypoparathyroidism in Turkey. This is a retrospective, cross-sectional database study, with collaboration of 30 endocrinology centers located in 20 cities across seven geographical regions of Turkey. A total of 830 adults (mean age 49.6 +/- 13.5 years; female 81.2%) with hypoparathyroidism (mean duration 9.7 +/- 9.0 years) were included in the final analysis. Hypoparathyroidism was predominantly surgery-induced (n = 686, 82.6%). The insulting surgeries was carried out mostly due to benign causes in postsurgical group (SG) (n = 504, 73.5%) while patients in nonsurgical group (NSG) was most frequently classified as idiopathic (n = 103, 71.5%). The treatment was highly dependent on calcium salts (n = 771, 92.9%), calcitriol (n = 786, 94.7%) and to a lower extent cholecalciferol use (n = 635, 76.5%) while the rate of parathyroid hormone (n = 2, 0.2%) use was low. Serum calcium levels were most frequently kept in the normal range (sCa 8.5-10.5 mg/dL, n = 383, 46.1%) which might be higher than desired for this patient group. NSG had a lower mean plasma PTH concentration (6.42 +/- 5.53 vs. 9.09 +/- 7.08 ng/l, p < 0.0001), higher daily intake of elementary calcium (2038 +/- 1214 vs. 1846 +/- 1355 mg/day, p = 0.0193) and calcitriol (0.78 +/- 0.39 vs. 0.69 +/- 0.38 mcg/day, p = 0.0057), a higher rate of chronic renal disease (9.7% vs. 3.6%, p = 0.0017), epilepsy (6.3% vs. 1.6%, p = 0.0009), intracranial calcifications (11.8% vs. 7.3%, p < 0.0001) and cataracts (22.2% vs. 13.7%, p = 0.0096) compared to SG. In conclusion, postsurgical hypoparathyroidism is the dominant etiology of hypoparathyroidism in Turkey while the nonsurgical patients have a higher disease burden with greater need for medications and increased risk of complications than the postsurgical patients.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.relation.ispartofCalcified Tissue Internationalen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHypoparathyroidismen_US
dc.subjectHypocalcemiaen_US
dc.subjectEpidemiologyen_US
dc.subjectTurkeyen_US
dc.subjectParathyroid hormoneen_US
dc.titleIdentifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Studyen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.authoridTurhan Iyidir, Ozlem/0000-0001-5305-6807
dc.authoridSAYGILI, Emre Sedar/0000-0003-0022-5704
dc.authoridyılmaz, merve/0000-0002-3421-8548
dc.authoridTURA BAHADIR, Çiğdem/0000-0001-6492-3064
dc.authoridGogas Yavuz, Dilek/0000-0002-0075-6313
dc.authoridTanrikulu, Seher/0000-0001-9220-6118
dc.authoridDegertekin, Ceyla Konca/0000-0003-0299-6596
dc.identifier.volume110en_US
dc.identifier.issue2en_US
dc.identifier.startpage204en_US
dc.identifier.endpage214en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85114447165en_US
dc.identifier.doi10.1007/s00223-021-00908-2
dc.department-temp[Degertekin, Ceyla Konca; Yilmaz, Banu Aktas] Ufuk Univ, Fac Med, Dept Endocrinol & Metab, Ankara, Turkey; [Degertekin, Ceyla Konca] Ufuk Univ Hastanesi, Endokrinol BD, Mevlana Bulvari Konya Yolu 86-88 Balgat, Ankara, Turkey; [Yavuz, Dilek Gogas] Marmara Univ, Fac Med, Dept Endocrinol & Metab, Istanbul, Turkey; [Pekkolay, Zafer] Dicle Univ, Fac Med, Dept Endocrinol & Metab, Diyarbakir, Turkey; [Saygili, Emre] Canakkale Mehmet Akif Ersoy State Hosp, Endocrinol & Metab Clin, Canakkale, Turkey; [Ugur, Kader; Kilinc, Faruk] Firat Univ, Fac Med, Dept Endocrinol & Metab, Elazig, Turkey; [Koca, Arzu Or] Kecioren Training & Res Hosp, Endocrinol & Metab Clin, Ankara, Turkey; [Unubol, Mustafa] Adnan Menderes Univ, Fac Med, Dept Endocrinol & Metab, Aydin, Turkey; [Topaloglu, Omercan] Kocaeli Derince Training & Res Hosp, Endocrinol & Metab Clin, Kocaeli, Turkey; [Aydogan, Berna Imge] Batman Training & Res Hosp, Endocrinol & Metab Clin, Batman, Turkey; [Kutbay, Nilufer Ozdemir; Hekimsoy, Zeliha] Manisa Celal Bayar Univ, Fac Med, Dept Endocrinol & Metab, Manisa, Turkey; [Yilmaz, Nusret; Balci, Mustafa Kemal] Akdeniz Univ, Fac Med, Dept Endocrinol & Metab, Antalya, Turkey; [Tanrikulu, Seher] Haydarpasa Numune Training & Res Hosp, Endocrinol & Metab Clin, Istanbul, Turkey; [Unsal, Yasemin Aydogan; Ersoy, Canan] Bursa Uludag Univ, Fac Med, Depten_US
dc.identifier.wosWOS:000695738900001en_US
dc.identifier.pmid34495356en_US
dc.authorwosidAydoğan, Berna İmge/A-2176-2019
dc.authorwosidTurhan Iyidir, Ozlem/K-7904-2019
dc.authorwosidyılmaz, merve/IXX-0825-2023
dc.authorwosidSAYGILI, Emre Sedar/K-8579-2019
dc.authorwosidTURA BAHADIR, Çiğdem/HKW-4615-2023
dc.authorwosidGogas Yavuz, Dilek/GRR-7277-2022
dc.authorwosidTanrikulu, Seher/GNP-0585-2022


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster